There is emerging data supporting the value of texture and other radiomics features extracted from dynamic contrast-enhanced (DCE) MRI to characterize breast cancer subtypes and recurrence risk. DCE texture features may also provide unique value in predicting response to neoadjuvant chemotherapy (NAC). Our study investigated the predictive value of pretreatment DCE tumor texture features in 30 women with triple negative and luminal-B cancers undergoing NAC. We found higher-order texture features significantly predicted pathologic response, while other standard quantitative metrics did not. Our findings suggest texture features on DCE MRI may provide valuable information prior to treatment to help tailor therapies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords